Clear Scientific, Inc.
Clinical trials sponsored by Clear Scientific, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental drug aims to curb meth high in small trial Results expected Sep 2026 (estimated)
-
New drug CS-1103 tested as potential fentanyl overdose treatment
Disease control Recruiting nowThis Phase 2 trial tests a single dose of CS-1103 in 16 healthy adults who also receive fentanyl (a strong opioid) and naloxone (an overdose reversal drug). The goal is to see if CS-1103 is safe and how it affects fentanyl levels in the body. It is an early study to gather safety…
Phase 2 • Sponsor: Clear Scientific, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Experimental drug aims to curb meth high in small trial
Disease control Recruiting nowThis study tests an experimental drug called CS-1103 in 40 healthy adults with methamphetamine use disorder who are not seeking treatment. Participants receive a single dose of methamphetamine along with CS-1103 to see if the drug can safely reduce the effects of intoxication. Th…
Phase 2 • Sponsor: Clear Scientific, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC